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ABSTACT  
Human Immunodeficiency Virus (HIV) and Tuberculosis(TB) have synergistic interactions that speedily accelerate decline of 
the host’s immune system and accentuate the progression of each other. Eight hundred and ninety five patients referred from 
different units of University of Benin Teaching Hospital, Nigeria were screened for antibodies to HIV-1 and HIV-2 using ELISA 
and sputum microscopy for acid-fast bacilli. The result showed that, 92(10.3%) were HIV positive with females 68(14.2%) higher 
than males 24(5.8%) though not statistically significant (p=0.066), 123(13.7%) patients were AFB positive, with males 75(18.1%) 
significantly higher than females 48(10%) (p=0.046) and 14(1.6%) patients were co-infected. Although the co-infection rate was 
higher among females 9(1.9%) than males 5(1.2%), there was no significant difference (p=0.450). The age group 40-49 and 50-59 
had the highest TB/HIV co-infection (2.5% each).Regular screening for TB in HIV patients and HIV in TB patients would 
demonstrate the true burden of TB disease amongst HIV infected patients. 
Key words: prevalence, TB, HIV, co-infection, Nigeria. 
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RESUME  
Le virus de l’immunodéficience humaine(VIH) et la tuberculose (TB) ont des interactions synergiques qui rapidement 
accélèrent le déclin du système immunitaire de l’hôte et accentuent la progression de l’un l’autre. Huit cent quatre – vingt 
quinze patients des différentes unités de l’université hôpital d’enseignement de Benin, Nigeria, ont été criblés pour les 
anticorps a VIH – 1 et VIH – 2 en utilisant ELISA microscopique des expectorations pour les bacilles acide – Résistant. Le 
résultat a montrée que 92 (10,3%) étaient séropositifs avec des femelles 68(14,2%) plus élevé que les males 24(5,8%), mais pas 
statiquement significatif, (p=0,066), 123(13,7%) patients étaient AFB positif, avec les males 75(18,1%) significativement plus 
élevés que les femelles 48 (10%) (p=0,046) et 14 (1,6%) patients ont été Co – infectés. Bien que le taux de la Co – infection était 
plus élevé parmi les femelles 9(1,9%) que les males 5 (1,2%), il n y avait pas de différence significative (p=0,450). Le groupe 
d’âges 40 – 49 et 50 – 59 avait la plus forte Co -  infection de TB/HIV (2,5%). Le dépistage régulier de la tuberculose chez les 
patients VIH et VIH chez les patients tuberculeux démontrerait le véritable fardeau de la maladie de la tuberculose chez les 
patients infectés par le VIH. 
Mots Clés : Prevalence, Tuberculose, VIH, Co – infection, Nigeria. 
INTRODUCTION                                                                                                                                                                       
Data from World Health Organization (WHO) shows 
that tuberculosis is the most common cause of death 
from infectious diseases, causing more death than 
HIV and malaria combined; with Africa harboring 
about 29% of those infected. Nigeria is one of the 
countries in sub-Saharan Africa noted to be saddled 
with a high prevalence of the disease [1]. It is known 




to have the highest burden of tuberculosis infection in 
Africa (311 per 100,000, about 0.31% of the 
population) [2].  The prevalence of HIV infection in 
Nigeria is high; approximately 3.6% of the population 
(about 3 million people) is known to be living with 
HIV infection [2].  The country has the second largest 
number of people living with HIV-AIDS and accounts 
for 10% of the global HIV burden with approximately 
215,000 HIV-AIDS related death in 2010 [2]. HIV 
infection is the single most important factor for the 
resurgence of TB globally and the major reason for 
failure to achieve set TB control targets especially in 
areas with high prevalence [3]. 
HIV and TB have synergistic interactions that 
speedily accelerate the decline of the host immune 
system, accentuating the progression of each other [4]. 
In the individual patient, HIV infection weakens the 
immune system and increases the susceptibility to TB. 
HIV increases the likelihood of reactivation, re-
infection and progression of latent TB infection to 
active disease. It also alters the clinical presentation of 
TB, complicates the follow up and compromises the 
response to anti-TB treatment [5].  
There were an estimated 1.1 million TB/HIV co-
infected patients worldwide in 2011; 79% of these 
cases were in the African Region [6]. This is due to the 
high incidence of HIV in this region. HIV and TB are 
the two leading causes of death and continued to be a 
serious problem in developing countries [7].  People 
living with HIV/AIDS (PLWHA) have an exquisite 
vulnerability to TB and are 30-50 times more likely to 
progress to active TB, while the likelihood of 
progressing to full blown AIDS increases by 100 folds 
in HIV/TB co infected patients [8]. HIV/TB co-
infection presently poses serious and major public 
health challenges especially in the African region, 
especially Nigeria. With a population of 162 million 
people, Nigeria is one of five countries with high 
TB/HIV burdens contributing 60% of the global HIV-
associated TB in 2011 [6]. In Nigeria the prevalence of 
HIV among TB patients increased from 2.2% in 1991 
to 19.1% in 2001 and 25% in 2010, indicating that the 
TB situation in the country is HIV-driven [9]. The 
need to define optimal timing of antiretroviral 
therapy during TB treatment and to find better 
alternatives to current drug regimens has been 
reasonably answered in Camelia, Sapit trials [10] . To 
mitigate the dual burden of TB/HIV in populations at 
risk of or affected by both diseases, the World Health 
Organization (WHO) published a document on 
priority research questions in 2010 [11], and an 
updated policy on collaborative TB/HIV activities in 
2012 [6], which emphasize the importance of 
surveillance of HIV among TB patients and 
surveillance of active TB patients among people living 
with HIV in all countries. 
In Benin City, Edo state, Nigeria, there is sketchy 
literature on prevalence of HIV and TB co-infection 
and associated risk factors. This study was carried out 
to determine the prevalence of HIV and TB co-
infection among patients attending University of 
Benin Teaching Hospital, Benin City, South-southern 
Nigeria. 
MATERIALS AND METHODS 
Study design  
This was a prospective cross sectional study carried 
out between January, 2014 and December, 2014 in 
which subjects referred from Accident & Emergency 
unit , Children Emergency unit, Outpatient clinics, 
Wards and TB  centers to Medical Microbiology 
laboratory for sputum AFB examination and HIV 
testing were recruited for this study after obtaining  
inform consent 
Study area 
The study was conducted at the University of Benin 
Teaching Hospital, Benin City, Nigeria. The 
institution is located in the heart of Edo state and 
serves as a referral centre to other neighbouring 
health institutions in Western and South-South 
regions of Nigeria. The facility also serves as a 
regional center for TB and HIV control programmes 
in Nigeria. 
Collection of samples 
Sputum samples were collected based on the 
conventional method of on the spot day one, early 
morning and on the spot on day two or 3 (first) early 
morning specimens obtained after a deep, productive 
cough on consecutive days using clean transparent 
wide-mouthed sputum cups. Specimens were 
brought to the Medical Microbiology laboratory on 
the day of collection. 
Sputum analysis for AFB                                                   
                     
The sputum samples were handled in a class I safety 
cabinet. Sputa accepted were purulent, opaque or 
greenish in appearance with less than 10 epithelial 
cells/l pf on Gram staining. Smears were made on 
grease free clean frosted slides, air-dried, heat-fixed 
and stained according to the standard operating 
procedure for the hot Ziehl Neelsen technique [12]. 
Smears were examined microscopically for acid fast 
bacilli (AFB) using oil immersion objective lenses and 
results were recorded appropriately.  
HIV Screening                                                                      
                 
Blood samples were obtained by vene-puncture and 
centrifuged, and the sera obtained were screened for 




antibodies to HIV-1 and HIV-2 using approved ELISA 
kits (Alere Determine™ and Double Check Gold™) 
(Alere industries, Japan), according to the 
manufacturer's instructions. Samples that tested 
positive were confirmed by Western blot. 
Ethical Approval                                                                 
                 
Ethical approval was obtained from the Ethics Review 
Board of UBTH and informed consent was obtained 
from all study subjects. 
Data analysis                                                                         
                      
The prevalence of HIV, TB and their co- infection was 
calculated.  The data generated was subjected to non-
parametric Mann-Whitney statistics and chi-square to 
determine any significant relationship between 
infection rate, age and gender. All statistical analyses 
were carried out using SPSS computer software 
version 16.0 for Windows. Significant and non-
significant difference was determined at p≤ 0.05 and 
p>0.05 respectively. 
Inclusion and Exclusion Criteria                                                                                                                                                    
Newly diagnosed subjects who gave informed 
consent and provided sputum and blood for AFB test 
and HIV screening respectively were included, while 
those who decline to give consent or were unable to 
produce sputum were excluded from the study. Also, 
subjects who had already been diagnosed with TB 
and HIV and were already on therapy were excluded 
from the study. 
LIMITATIONS OF THE STUDY                                    
The selection of patients from a single center poses a 
major limitation for the applicability and 
generalization of the findings. The finding is also 
limited because participation was voluntary. The 
analysis was only restricted to smear-positive 
tuberculosis cases which is not enough to accurately 
diagnosed Mycobacterium tuberculosis. However, we 
believe that these not invalidate the study.  
RESULTS                                                                                                                  
Eight hundred and ninety five (895) patients were 
included in this study. Most of these patients were 
referred from the outpatient clinic (32.3%) and TB 
centers (31.8%), while 18.8%, 9.75 and 7.4% were 
referred from the wards, Accident and emergency 
and children emergency center respectively (Table 1). 
The result in Table 2 showed that, of the total 
populations, 415(46.4%) were males while 480(53.6%) 
were females, with a male: female ratio of 0.87:1. 
Ninety-two patients (10.3%) were HIV positive with 
females 68(14.2%) showing a higher prevalence rate 
than males 24(5.8%) but with no statistical difference 
(p=0.066). The results further showed that 123(13.7%) 
patients are AFB positive with males 75(18.1%) 
showing significantly higher prevalence rate than 
females 48(10%) (p=0.046). The result of the co-
infection rate among these populations showed that 
14(1.6%) patients were co-infected with both AFB and 
HIV. Although the co-infection rate was higher in 
females 9(1.9%), the result however, showed no 
statistically significant difference (p=0.450). 
TABLE 1: REFERRAL DISTRIBUTION OF PATIENTS 
FOR HIV AND AFB TEST FROM DIFFERENT UNITS 
S/N Referred 
from 
Frequency  Percentage 
1 A/E 87 9.7 
2 CHER 66 7.4 
3 CLINIC 289 32.3 
4 DOT 285 31.8 
5 WARD 168 18.8 
 TOTAL 895 100 
Key: A/E= accident and emergency, DOT= direct observed 
therapy, CHER = children emergency 
    
TABLE 2: SEX DISTRIBUTION OF HIV, AFB AND 
AFB/HIV CO-INFECTION 
Sex     No. Tested    HIV+   AFB +    HIV/AFB co-infection 
Male   415      24 (5.8)     75 (18.1)       5 (1.2) 
Female  480      68 (14.2)    48 (10)  9 (1.9) 
Total  895      92 (10.3)    123 (13.7) 14 (1.6) 
Age distribution of patients in this study is presented 
in Table 3. The age group with the highest HIV 
infection rate was 30-39 years (17.8%), with females 
(21.2%) having higher prevalence rate than males 
(13%) (Table 4). Also, TB infection is much more 
prevalent in the age group 30-39 years (17.8 %), with 
males (24%) having higher prevalence rate than 
females (12.4%). The age groups 40-49 years and 50-59 
years had the highest TB/HIV co-infection (2.5% 








TABLE 3: AGE DISTRIBUTION OF HIV, AFB AND AFB/HIV CO-INFECTION 
Age distribution No. Tested Sex No. of HIV 
positive(%) 
No. of AFB 
positive(%) 
AFB/HIV Co-
infection Male Female 
0-9 18(2.0) 10 8 0 (0) 1(5.6) 0(0) 
10-19 63(7.0) 37 26 3(4.8) 8(12.7) 1(1.6) 
20-29 167(18.7) 77 90 15(8.9) 25(14.9) 1(0.6) 
30-39 213(23.8) 100 113 37(17.4) 38(17.8) 3(1.4) 
40-49 118(13.2) 53 65 14(11.9) 13(11.0) 3(2.5) 
50-59 120(13.4) 50 70 13(10.8) 16(13.3) 3(2.5) 
60-69 118(13.2) 57 61 6(5.1) 15(12.7) 2(1.7) 
70 and above 78(8.7) 31 47 4(5.1) 7(8.9) 1(1.3) 
Total 895(100) 415(46.4) 480(53.6) 92 (10.3) 123(13.7) 14 (1.6) 
 
TABLE 4: AGE AND SEX DISTRIBUTIONS OF HIV, AFB AND AFB/HIV CO-INFECTION 
Age 
distribution 
No. Tested (%) HIV positive (%) AFB positive (%) AFB/HIV Co-infection (%) 
 Male Female Male Female Male Female Male Female 
0-9 10(55.6) 8(44.4) 0(0) 0(0) 0(0) 1(12.5) 0(0) 0(0) 
10-19 37(58.7) 26(41.3) 1(2.7) 2(7.7) 4(10.8) 4(15.4) 1(2.7) 0(0) 
20-29 77(46.1) 90(53.9) 2(2.6) 13(14.4) 15(19.5) 10(11.1) 0(0) 1(1.1) 
30-39 100(46.9) 113(53.1) 13(13) 24(21.2) 24(24) 14(12.4) 2(2) 1(0.9) 
40-49 53(44.9) 65(55.1) 2(3.8) 12(18.5) 8(15.1) 5(7.7) 0(0) 3(4.6) 
50-59 50(41.7) 70(58.3) 1(2) 12(17.1) 10(20) 6(8.6) 1(2) 2(2.9) 
60-69 57(48.3) 61(51.7) 3(5.3) 3(4.9) 9(15.8) 6(9.8) 1(1.8) 1(1.6) 
70 and above 31(39.7) 47(60.3) 2(6.5) 2(4.3) 5(16.1) 2(4.3) 0(0) 1(2.1) 
Total 415(46.4) 480(53.6) 24(5.8) 68(14.2) 75(18.1) 48(10) 5(1.2) 9(1.9) 
 
DISCUSSIONS                                                                   
The results of this study showed that more females 
(53.6%) were screened for both HIV and TB compared 
with males (46.4%).  This is in agreement with a 
similar study earlier reported from Nnewi, Nigeria 
[4]. Another similar study in the Niger-Delta region of 
Nigeria revealed that females (64%) participated more 
in the study than their male (36%) counterpart [13].  
Naturally, females tend to seek medical attention 
much earlier than males who in keeping with their 
stronger-sex and bread winner tendencies would not 
go to hospital until later during the course of their 
illness[4]. 
A non-significant rate of HIV infection was found to 
be higher among females (14.2%) than males (5.8%), a 
finding contrary to that from Gombe, Nigeria[14] 
where males had a higher prevalence. This rising 
trend in female HIV prevalence is not unexpected due 
to the fact that the penile-vaginal transmission by an 
infected individual in a single sexual exposure is as 
low as one in 1000 from woman to man and as high as 
one in 300 from man to woman [15]. In addition, early 
exposure to sexual activities, the  poor economic 
status and the pressure on women to provide for their 
families as well as the lack of ability to negotiate safer 
sex [16, 17, and 18]  might have contributed to the 
increase in the risk of  HIV acquisition among 
women. A relative reason for the disparity could be 
the high health-seeking behavior of women. 
Furthermore, the age group with the highest HIV 
infection is 30-39 (17.8%). This is consistent with  
 
previous report in Nigeria [18 and 19]. Individuals in 
this age group make up a greater proportion of the 
workforce in the country thus the impact of HIV/TB 
co-infection on the economy of the country will 
certainly become over- whelming if not controlled 
with appropriate intervention measures such as 
provision of effective prevention education and  early 
detection and treatment of both infections [18].  
However, other report showed that the pattern of 
HIV infection in the general population is highest 
among individuals in the age group 20-29 [20]. The 
result of this study also showed that none of the 
subjects tested among age group 0-9 is HIV positive. 
This might be due to the fact that this age group are 
less vunerable to risk factors for HIV infections . The 
age group 10-19 (4.8%) has the lowest HIV infection 
rate among the studied population. This is consistent 
with earlier report [18] and with previous national 
data [21] and may indicate less HIV associated 
acquisition of TB in this age group. 
This study showed that TB infection is correlated with 
gender, with males (18.1%) showing significant 
higher prevalence rate than females (10%) (p=0.046). 
Contrary to the findings of this study, Onubogu et al. 
[22] reported that TB infection rate was statistically 
higher in females than in males. According to them, 
the differences in the infection rate in females and 
males could be as a result of biological factors such as 
higher susceptibility to infection due to low immunity 
in women. However, this finding is in agreement with 




previous studies [23, 24 and 25] which reported that 
TB infection was more in males than females. Obiora 
et al. [26] also reported higher TB infection rates 
among males in Benin and Irrua, Nigeria. Nnorom et 
al. [27] reported higher TB infection rates for TB 
among males in urban and rural communities in 
Nigeria. The reason for the gender difference in 
prevalence of TB and HIV is not known from our 
study. However, it seems probable that a combination 
of different factors such as biological differences in 
disease and disease presentation, together with 
gender related factors like access to health care may 
play a role. Biological and immunological factors 
might be contributory as to why evidence which 
suggest that men may have more infectious TB 
(smear-positive pulmonary TB) than women [28]. A 
theory that is often presented as an explanation to the 
gender differences is that men in general have a wider 
social network that leads to a greater exposure to the 
tubercle bacillus. A population study [29] among 
people with a cough for more than 3 weeks reported 
that although women did not start seeking health care 
later than men, they often sought health care from 
less qualified providers, took more health care 
actions, and had longer delay to hospital than men. In 
a study on TB patients by Matsushita et al. [30], in 
Japan, they observed that the stage and the extent of 
lung lesions are less advanced among female TB 
patients. So the prevalence of cough and sputum 
expectoration among female TB patients was 
significantly less common than among male patients. 
In many low-income countries, women often have a 
lower social position and poorer access to economic 
resources, education, and information than men. 
These gender differences influence both health risks 
among women and care-seeking behaviour [31]. 
Although our study showed that age group is not a 
risk factor with regard to TB infection, however, the 
age group 30-39 (17.8%) are more predisposed to TB 
infection. This is contrary to previous reports from 
Nigeria [32] and Turkey [33], but is consistent with a  
previous study reported from Tanzania [34]. 
The result of the co-infection rate among these 
populations showed  that 14(1.6%) patients are co-
infected with both TB and HIV. The HIV-TB co 
infection rate of 1.6% obtained in this study could be 
comparable to 1.42% reported from a tertiary care 
hospital in Nnewi, Nigeria [4] and 1.23% obtained in 
a rural tertiary care hospital in Punjab [35]. However, 
it was quite lower than those obtained from other 
states of Nigeria where rates ranging from 4.39% to 
41.2% have been documented [17, 19, 22, 36-42]. Co-
infection rates could vary between study populations 
and regions, probably due to differences in prominent 
occupation and other socio-economic factors [43] and 
differences in study designs [36]. The low prevalence 
of TB-HIV co-infection as observed in this study may 
not be unconnected with the increased awareness of 
HIV infection and increase in the number of free 
treatment centres, provided by the Government and 
NGO’s in the country.  It might also be due to the fact 
that all the subjects involved in this study are 
ignorant of their HIV or TB status until confirmed in 
the laboratory. Although the co-infection rate was 
higher in females 9(1.9%) than in males 5(1.2%), the 
result however, showed no statistically significant 
difference (p=0.450). This observation is in agreement 
with previous studies that reported 6.85% TB-HIV co-
infection in females and 4.95% prevalence rate in 
males [37]. Contrary to the findings of this study, 
previous report showed that TB and HIV co-infection 
rate was also higher among females than males but 
the difference was statistically significant ([44, 22]. 
Difference in co-infection rate in males and females 
could be as a result of early exposure of females to 
sexual activity due to their economically 
disadvantaged position, high susceptibility to 
infection [45], delay in care seeking due to stigma 
associated with HIV infection [46]; less access to fund 
for transportation and personal health care [22], high 
incidence of HIV infection in females which 
predisposes them to TB as the former is known to 
activate dormant TB [47]. Other studies contrary to 
the findings of this study also revealed higher 
TB/HIV co-infection rates among males than females 
[48, 49]. This was attributed to the general attitude of 
males towards indiscriminate sex especially when 
they travel away from their families and visit sex 
tourist centres [48].  
The rising cases of TB/HIV co-infection no doubt 
impacts negatively on AIDS and TB control 
programmes in many ways, this includes increased 
caseload of active TB attributable to HIV, HIV-related 
morbidity and mortality in TB patients, higher default 
rates and low cure rates, high rate of adverse drug 
reactions, increased risk of TB transmission and delay 
of access to health services for TB suspects due to the 
stigma of HIV/AIDS [50]. 
CONCLUSION 
There are genders and age differences in the HIV 
prevalence and HIV-TB co infection rates among the 
study subjects. However, the study also demonstrates 
that gender rather than age group is a risk factor for 
TB infection with males’ preponderance. Therefore it 
is strongly recommended that Patients with newly 
diagnosed TB should be tested for HIV infection and 
patients with newly diagnosed HIV be tested for TB 
infection. 
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